Cipla shares rise marginally post agreement with CitiHealth Imports
- Country:
- India
Shares of Cipla on Thursday rose nearly 2 per cent after the pharma major said its arm has signed an agreement with CitiHealth Imports to acquire remaining 40 per cent stake in Cipla Pharma Lanka. On the BSE, the stock hit intra-day high of Rs 476.35, up 1.83 per cent. It settled 0.22 per cent up at Rs 468.80.
During the day, the scrip moved 1.81 per cent up to Rs 476.50 on the NSE. It closed the session 0.26 per cent up at Rs 469.20. The BSE saw an exchange of 1.03 lakh shares whereas, the NSE witnessed trade of over 29 lakh shares of Cipla.
The pharma company on Wednesday said its arm Cipla (EU) Ltd has signed an agreement with CitiHealth Imports to acquire remaining 40 per cent stake in Cipla Pharma Lanka. Cipla (EU) Ltd already has a 60 per cent stake in Cipla Pharma Lanka Pvt Ltd. Post-acquisition, Cipla Pharma Lanka will become a wholly-owned subsidiary, Cipla said in a filing to the BSE.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- BSE
- Cipla
- Cipla Pharma Lanka
- NSE
ALSO READ
Entertainment News Roundup: ‘Absence of Eden’ cast and creators highlight humanity of immigrants; Tennis drama 'Challengers' showcases Zendaya's versatility and more
ECI directs over 350 observers to ensure smooth, free and fair polling on 19th April, 2024
Hurriyat Conference condemns 'restrictions on religious observances'
AAP to observe 'Samvidhan Bachao, Tanashahi Hatao Divas' across nation on Sunday
Himachal: Congress releases list of observers for three Lok Sabha seats